HIIFS
GBT

Harel Insurance Investments & Financial Services’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,000
Closed -$45K – 525
2018
Q2 		$45K Buy
+1,000
New +$45.5K ﹤0.01% 306

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Harel Insurance Investments & Financial Services's GBT Position: Q3 2018 in Review

Harel Insurance Investments & Financial Services sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2018, closing a stake of 1,000 shares — an estimated $45K sold.

Harel Insurance Investments & Financial Services first reported a position in GBT in Q2 2018 and held it in 1 quarter. The position peaked at $45K in Q2 2018. 184 funds tracked by Wall St. Rank hold GBT as of Q3 2018.

  • Harel Insurance Investments & Financial Services reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 1,000 Global Blood Therapeutics, Inc. shares in Q3 2018, an estimated $45K.
  • Harel Insurance Investments & Financial Services first reported a position in Global Blood Therapeutics, Inc. in Q2 2018 and held it in 1 quarter.
  • Harel Insurance Investments & Financial Services's Global Blood Therapeutics, Inc. position peaked at $45K in Q2 2018.
  • 184 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2018.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2018, filed 29 Oct 2018.